0

Global B-cell non-Hodgkin lymphoma drugs market 2018-2022

  • Published: Aug 2018
  • Pages: 105
  • SKU: IRTNTR23643
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The global B-cell non-Hodgkin lymphoma drugs market is predicted to reach a size of more than USD 7.6 billion by 2022. Wondering how to make the most of this thriving industry? Technavio’s extensive industry research report offers a detailed insight that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by B-cell lymphoma treatment category and by region. It also examines the competitive landscape and some leading vendors that include Biogen, F. Hoffmann-La Roche, and Merck.

Here are some crucial facts about the global B-cell non-Hodgkin lymphoma drugs industry

 

 

 

 

 

 

 

 

 

 

 

The global B-cell non-Hodgkin Lymphoma drugs market is expected to expand at a CAGR of more than 7% by 2022

B-cell non-Hodgkin lymphoma drugs industry growth is expected to accelerate over the next five years, driven by rising count of pipeline molecules for B-cell lymphoma treatment. The Americas will drive almost two-fourth of the growth of B-cell non-Hodgkin lymphoma drugs market, while EMEA and APAC are also forecasted to make substantial contributions to the incremental growth in the forecast period. The Americas held the largest market share in 2017 due to increasing prevalence of B-cell non-Hodgkin lymphoma in the region. However, the Americas and EMEA are likely to witness a decline in their market share at the end of the forecast period, while APAC looks poised to experience a higher rate of growth in the same period due to rapid technological advancements. Technavio’s B-cell non-Hodgkin lymphoma drugs industry analysis reveals promising markets around the world.

Want a bigger picture? Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

 

Growing initiatives taken by the government is driving the demand for B-cell lymphoma treatment

Increasing funding initiatives by the government such as Cancer Breakthroughs 2020 which is likely to augment the growth of the B-cell non-Hodgkin lymphoma drugs market during the period of forecast. Also, the leading B-cell non-Hodgkin lymphoma drugs manufacturers are focusing on offering physician support programs to promote the best cure for non-Hodgkin lymphoma such as IMBRUVICA (ibrutinib), YESCARTA (Axicabtagene Ciloleucel), and Rituxan (Rituximab) which will contribute to the growth of the B-cell non-Hodgkin lymphoma drugs market in the next five years.

 

Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services.      Start your 14-day FREE trial

 

Biogen, F. Hoffmann-La Roche, and Merck are among the leading B-cell non-Hodgkin lymphoma drug manufacturers

Most of the leading vendors in the global B-cell non-Hodgkin lymphoma drugs market are focused on increasing the number of clinical trials for the development of B-cell non-Hodgkin lymphoma drugs. Furthermore, the approval of new therapeutic agents is likely to broaden the scope of the cure for non-Hodgkin lymphoma. The global B-cell non-Hodgkin lymphoma is predicted to experience a significant growth in the forecast period owing to increasing prevalence of non-Hodgkin lymphoma across the globe. Many international and regional vendors are vying for their share of the market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

  • Biogen
  • F. Hoffmann-La Roche
  • Merck
  • Novartis
  • Spectrum Pharmaceuticals

 

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements.  Get in touch

 

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE LANDSCAPE

PART 08: MARKET SEGMENTATION BY CATEGORY

  • Segmentation by category
  • Comparison by category
  • Small molecules - Market size and forecast 2017-2022
  • Biologicals - Market size and forecast 2017-2022
  • Market opportunity by category

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • B-cell NHL drugs market in Americas
  • B-cell NHL drugs market in EMEA
  • B-cell NHL drugs market in APAC
  • Market opportunity

PART 10: CUSTOMER LANDSCAPE

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Strong pipeline
  • Strategic alliances
  • Advanced technologies

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Biogen
  • F. Hoffmann-La Roche
  • Merck
  • Novartis
  • Spectrum Pharmaceutical

PART 16: APPENDIX

  • List of abbreviations

 

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>